Navigation Links
New 'smart' nanotherapeutics can deliver drugs directly to the pancreas
Date:1/12/2012

BOSTON, January 12, 2012: A research collaboration between the Wyss Institute for Biologically Inspired Engineering at Harvard University and Children's Hospital Boston has developed "smart" injectable nanotherapeutics that can be programmed to selectively deliver drugs to the cells of the pancreas. Although this nanotechnology will need significant additional testing and development before being ready for clinical use, it could potentially improve treatment for Type I diabetes by increasing therapeutic efficacy and reducing side effects.

The approach was found to increase drug efficacy by 200-fold in in vitro studies based on the ability of these nanomaterials to both protect the drug from degradation and concentrate it at key target sites, such as regions of the pancreas that contain the insulin-producing cells. The dramatic increase in efficacy also means that much smaller amounts of drugs would be needed for treatment, opening the possibility of significantly reduced toxic side effects, as well as lower treatment costs.

The research was led by Wyss Institute Founding Director Donald Ingber M.D., Ph.D. and Kaustabh Ghosh, Ph.D., a former postdoctoral fellow at Children's Hospital Boston. Their findings appear in the current issue of Nano Letters. Ingber is also the Judah Folkman Professor of Vascular Biology at Harvard Medical School and Children's Hospital Boston, and Professor of Bioengineering at Harvard's School of Engineering and Applied Sciences. Ghosh is now an Assistant Professor of Bioengineering at the University of California, Riverside. Wyss Institute Postdoctoral Fellows, Umai Kanapathipillai and Netanel Korin, also contributed to the work, as did Jason McCarthy, Assistant Professor in Radiology at Harvard Medical School and an Assistant in Chemistry at Massachusetts General Hospital.

Type I diabetes, which often strikes children and young adults, is a debilitating disease in which the body's immune system pro
'/>"/>

Contact: Twig Mowatt
twig.mowatt@wyss.harvard.edu
617-432-1547
Wyss Institute for Biologically Inspired Engineering at Harvard
Source:Eurekalert

Page: 1 2

Related biology news :

1. WPI receives $1.2 million to develop smart phone app for advanced diabetes and wound care
2. SmartActions Artificial Intelligence IVR Solution Receives PCI Certification
3. Climate-smart agriculture should be livelihood-smart too
4. Smart swarms of bacteria inspire robotics researchers
5. NIH awards group $4.5 million for smart artificial pancreas technology
6. Smarter toxins help crops fight resistant pests
7. Caltech engineers build smart petri dish
8. Card Logistics to Auction Smart Card Gaming Technology at Upcoming ICAP Patent Brokerage Fall 2011 Live IP Auction in San Francisco
9. Sea smarts: Scientists reconstruct evolutionary history of mollusks
10. Outsmarting algae -- RIT scientist finds the turn-off switch
11. LCC science projects receive $1.2 million through WaterSMART program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , June 30, 2015 ... has announced the addition of the "Capacitive ... offering. To this date, fingerprint sensing ... technology and fingerprint sensors are well developed. This ... sensing technology. The domain of capacitive ...
(Date:7/7/2015)... 7, 2015  Based on its recent analysis ... recognizes Credence ID, LLC with the 2015 Asia-Pacific ... the Year Award. Credence ID has developed a ... mission of offering enrollment and identification solutions to ... ID was formed by experts from the mobile ...
(Date:7/7/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") a ... a revised version of one of its first 30 second commercials ... in New York , Chicago ... Francisco metro areas.    , , , ... all the cards in your wallet and keep your identity secure. ...
Breaking Biology News(10 mins):Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
... University of Manchester researchers are ridding diabetic patients of ... with maggots. , Professor Andrew Boulton and his team ... patients whose foot ulcers were contaminated with MRSA and ... period of three weeks, much quicker than the 28-week ...
... the nation are protesting a new and narrowed definition ... Monday to U.S. Secretary of the Interior Dirk Kempthorne, ... the House Committee on Natural Resources, they warn that ... the Solicitor of the U.S. Department of the Interior ...
... nerves in the mammalian brain’s white matter do more than ... process information the way gray matter cells do. , The ... the March issue of Nature Neuroscience, shows that brain cells ... , “We were surprised to see these nerve axons ...
Cached Biology News:Maggots rid patients of MRSA 2Legal ruling may put endangered species in danger 2Brain's white matter -- More 'talkative' than once thought 2
(Date:7/7/2015)... , July 7, 2015 ... - Gene Therapy Market Analysis" report is an ... gene therapy field. Using detailed company data, deal ... provides an in-depth analysis of the current and ... The report discusses the key factors shaping and ...
(Date:7/7/2015)... July 7, 2015 Genes in Space, ... 7-12, is landing at New England Biolabs® (NEB®) ... day of scientific exploration and celebration, on Thursday, ... partnership between Boeing®, The Center for Advancement of ... asked students to design an experiment to solve ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... biologic are some of the factors driving the pharmaceutical contract manufacturing market. BCC ... well as contract manufacturing organizations (CMOs), are driving market growth. Drug manufacturers are ...
(Date:7/7/2015)... ... July 07, 2015 , ... DNA Genotek, a ... OraSure Technologies, Inc. (NASDAQ: OSUR) today announced that its OMNIgene®•GUT microbiome collection kit ... declaration under the European Directive for In Vitro Diagnostic Medical Devices. , ...
Breaking Biology Technology:PharmaSphere: Emerging Biotechnologies - Gene Therapy Market Analysis 2Genes in Space finalists attend laboratory workshop and celebration at New England Biolabs' headquarters 2More Drug Companies Increasing Outsourcing Budgets; CMO Partners Spring Up as Market Thrives, According to BCC Research 2More Drug Companies Increasing Outsourcing Budgets; CMO Partners Spring Up as Market Thrives, According to BCC Research 3DNA Genotek Inc. Receives CE-IVD Mark for its OMNIgene®•GUT Microbiome Collection Kit 2
... CV Therapeutics,Inc. (Nasdaq: CVTX ) announced today that ... for the brand name Ranexa(R) (ranolazine)., On July ... granted,marketing authorization for ranolazine in all 27 European Union ... approval for the Ranexa brand name in Europe provides,important ...
... Named as CEO ... COO, ALTAMONTE SPRINGS, Fla., Aug. 14 Milestone ... and commercialization of niche oncology products, today,announced the appointment ... 12, 2008. Current President, CEO and Co-founder, Frank,Jacobucci, will ...
... Bio-,Pharmaceutical Technology, Inc (OTC Bulletin Board: HFGB), a ... raw materials,for use in pharmaceutical, nutraceutical and food ... for the three and six month periods,ended June ... 2008, sales of our products increased,substantially. Revenue received ...
Cached Biology Technology:CV Therapeutics Receives European Approval for the Brand Name Ranexa(R) 2Milestone Biosciences, LLC Further Strengthens Executive Management Team 2Huifeng Bio-Pharmaceutical (HFGB) Reports over $5 Million in Gross Sales; Record Results for the First Half of 2008 2